Significance of plasma levels of n-terminal pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the α-tropomyosin gene

被引:16
作者
Magga, Jarkko [1 ]
Sipola, Petri [2 ]
Vuolteenaho, Olli [3 ]
Risteli, Juha [4 ]
Jaaskelainen, Pertti [1 ]
Peuhkurinen, Keijo [1 ]
Kuusisto, Johanna [1 ]
机构
[1] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland
[2] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland
[3] Oulu Univ, Dept Physiol, Oulu, Finland
[4] Oulu Univ Hosp, Dept Clin Chem, Oulu, Finland
关键词
D O I
10.1016/j.amjcard.2007.11.071
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertrophic cardiomyopathy (HC) is an inherited heart disease characterized by left ventricular (LV) remodeling. The present study was conducted to investigate the association of N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) levels with LV remodeling on magnetic resonance imaging and procollagen formation in 17 healthy controls and 24 patients with nonobstructive HC attributable to an identical Asp175Asn (aspartic acid to asparagine at codon 175) mutation in the alpha-tropomyosin gene. None of the patients had history of decompensated heart failure, and all patients had normal LV ejection fraction. Patients with HC had higher NT-pro-BNP. levels compared with controls (median 60 pmol/L, range <40 to 359, vs <40 pmol/L; p <0.001), but 9 patients with HC had normal NT-pro-BNP levels (<40 pmol/L). In patients with HC, levels of NT-pro-BNP were correlated significantly with LV end-systolic volume index (r = 0.50, p <0.05), LV mass index (r = 0.47, p <0.05), proportion of hypokinetic segments (r 0.50, p <0.05), and levels of serum aminoterminal propeptide of type III procollagen (r = 0.52, p <0.01). When patients with HC were divided into 3 groups on the basis of their NT-pro-BNP levels, there were statistically significant linear associations of LV end-systolic volume (test for linearity p = 0.034), LV mass index (p = 0.009), proportion of hypokinetic segments (p = 0.016), and levels of serum aminoterminal propeptide of type III procollagen (p = 0.020) with NT-pro-BNP levels over the 3 groups, suggesting a tight relation between LV remodeling and levels of NT-pro-BNP. In conclusion, in patients with nonobstructive HC attributable to an Asp175Asn mutation in the alpha-tropomyosin gene, elevated NT-pro-BNP levels are associated with incipient LV remodeling, suggesting that NT-pro-BNP could be used to diagnose insidious unfavorable LV remodeling in HC. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1185 / 1190
页数:6
相关论文
共 29 条
[1]   Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy [J].
Arteaga, E ;
Araujo, AQ ;
Buck, P ;
Ianni, BM ;
Rabello, R ;
Mady, C .
AMERICAN HEART JOURNAL, 2005, 150 (06) :1228-1232
[2]   Determinants and clinical significance of natriuretic peptides in hypertrophic cardiomyopathy [J].
Briguori, C ;
Betocchi, S ;
Manganelli, F ;
Gigante, B ;
Losi, MA ;
Ciampi, Q ;
Gottilla, R ;
Violante, A ;
Tocchetti, CG ;
Volpe, M ;
Chiariello, M .
EUROPEAN HEART JOURNAL, 2001, 22 (15) :1328-1336
[3]   Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy [J].
Grothues, F ;
Smith, GC ;
Moon, JCC ;
Bellenger, NG ;
Collins, P ;
Klein, HU ;
Pennell, DJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (01) :29-34
[4]   VENTRICULAR EXPRESSION OF BRAIN NATRIURETIC PEPTIDE IN HYPERTROPHIC CARDIOMYOPATHY [J].
HASEGAWA, K ;
FUJIWARA, H ;
DOYAMA, K ;
MIYAMAE, M ;
FUJIWARA, T ;
SUGA, S ;
MUKOYAMA, M ;
NAKAO, K ;
IMURA, H ;
SASAYAMA, S .
CIRCULATION, 1993, 88 (02) :372-380
[5]   The cardiac β-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population [J].
Jääskeläinen, P ;
Soranta, M ;
Miettinen, R ;
Saarinen, L ;
Pihlajamäki, J ;
Silvennoinen, K ;
Tikanoja, T ;
Laakso, M ;
Kuusisto, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (06) :1709-1716
[6]   B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-β in primary human cardiac fibroblasts -: Fibrosis, myofibroblast conversion, proliferation, and inflammation [J].
Kapoun, AM ;
Liang, FQ ;
O'Young, G ;
Damm, DL ;
Quon, D ;
White, RT ;
Munson, K ;
Lam, A ;
Schreiner, GF ;
Protter, AA .
CIRCULATION RESEARCH, 2004, 94 (04) :453-461
[7]  
Magga J, 1997, CIRC RES, V81, P694
[8]   Atrial natriuretic peptide, B-type natriuretic peptide, and serum collagen markers after acute myocardial infarction [J].
Magga, J ;
Puhakka, M ;
Hietakorpi, S ;
Punnonen, K ;
Uusimaa, P ;
Risteli, J ;
Vuolteenaho, O ;
Ruskoaho, H ;
Peuhkurinen, K .
JOURNAL OF APPLIED PHYSIOLOGY, 2004, 96 (04) :1306-1311
[9]   Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy [J].
Maron, BJ ;
Tholakanahalli, VN ;
Zenovich, AG ;
Casey, SA ;
Duprez, D ;
Aeppli, DM ;
Cohn, JN .
CIRCULATION, 2004, 109 (08) :984-989
[10]   Experience from clinical genetics in hypertrophic cardiomyopathy: Proposal for new diagnostic criteria in adult members of affected families [J].
McKenna, WJ ;
Spirito, P ;
Desnos, M ;
Dubourg, O ;
Komajda, M .
HEART, 1997, 77 (02) :130-132